News & Articles 02/01/2024 Our Network Beyfortus approved in China for the prevention of RSV disease in infants First and only RSV preventive option authorised for use in China
News & Articles 12/12/2023 Research AstraZeneca to acquire Icosavax, including potential first-in-class RSV and hMPV combination vaccine with positive Phase II data Building on expertise in RSV prevention, acquisition will accelerate ambition to deliver portfolio of protective interventions to address high unmet needs in infectious diseases.
